Nasus Pharma Ltd (NSRX) stock
NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
$2.70+0.09 (+3.45%)
Close on Nov 18, 2026Market cap $24.34MP/E –Yield –
Nasus Pharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $1.24B.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.24B | – |
See a number that looks wrong?